Antifibrinolytic therapy (tranexamic acid or epsilon aminocaproic acid) vs placebo
Number of participants with any bleeding · People with a haematological disorder
1 finding from 1 review
- Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders 2016 · Cochrane Headline outcomes onlyno estimate extracted1 study · 56 participantsVery low